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 Abstract Text:  
  
This paper presents work in progress, to develop an efficient and economic way to 
directly produce Technetium 99metastable (99mTc) using low-energy cyclotrons. Its 
importance is well established and relates with the increased global trouble in 
delivering 99mTc to Nuclear Medicine Departments relying on this radioisotope.   Since 
the present delivery strategy has clearly demonstrated its intrinsic limits, our group 
decided to follow a distinct approach that uses the broad distribution of the low energy 
cyclotrons and the accessibility of Molybdenum 100 (100Mo) as the Target material.  
This is indeed an important issue to consider, since the system here presented, named 
CYCLOTECH, it is not based on the use of Highly Enriched (or even Low Enriched) 
Uranium 235 (235U), so entirely complying with the actual international trends and 
directives concerning the use of this potential highly critical material. The production 
technique is based on the nuclear reaction 100Mo (p,2n) 99mTc  whose production yields 
have already been documented. 
Until this moment two Patent requests have already been submitted (the first at the 
INPI, in Portugal, and the second at the USPTO, in the USA); others are being 
prepared for submission on a near future. 
The object of the CYCLOTECH system is to present 99mTc to Nuclear Medicine 
radiopharmacists in a routine, reliable and efficient manner that, remaining always 
flexible, entirely blends with established protocols. 
To facilitate workflow and Radiation Protection measures,  it has been developed a 
Target Station that can be installed on most of the existing PET cyclotrons and that will 
tolerate up to 400 μA of beam by allowing the beam to strike the Target material at an 
adequately oblique angle.  The Target Station permits the remote and automatic 
loading and discharge of the Targets from a carriage of 10 Target bodies. 
On other hand, several methods of Target material deposition and Target substrates 
are presented.  The object was to create a cost effective means of depositing and 
intermediate the target material thickness (25 - 100μm) with a minimum of loss on a 
substrate that is able to easily transport the heat associated with high beam currents. 
Finally, the separation techniques presented are a combination of both physical and 
column chemistry.  The object was to extract and deliver 99mTc in the identical form now 
in use in radiopharmacies worldwide.  In addition, the Target material is recovered and 
can be recycled. 
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